Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Kelly

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Global Spine Journal|May 9, 2025
Is Intraoperative Neuromonitoring with SSEPs and EMG Predictable for Postoperative Neurologic Deficit in Posterior Lumbar Fusion Surgery? A Retrospective Cohort AnalysisMarco D Burkhard, Gisberto Evangelisti, Franziska C S Altorfer, et al.
Nature Chemistry|August 25, 2017
The structure and binding mode of citrate in the stabilization of gold nanoparticlesHind Al-Johani, Edy Abou-Hamad, Abdesslem Jedidi, et al.
British Journal of Haematology|May 1, 2018
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomesSusan K Parsons, Michael J Kelly, Joshua T Cohen, et al.
Global Spine Journal|November 6, 2024
Multifidus Degeneration: The Key Imaging Predictor of Adjacent Segment DiseaseMarco D Burkhard, Erika Chiapparelli, Jan Hambrecht, et al.
Cancer|May 26, 2017
Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropeniaAdam J Esbenshade, Zhiguo Zhao, Catherine Aftandilian, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosisMark E Layton, Alexander J Reif, Timothy J Hartingh, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDIJoseph E Pero, Michael A Rossi, Michael J Kelly, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Discovery of Arylsulfonamide Na<sub>v</sub>1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity ProfileAnthony J Roecker, Mark E Layton, Joseph E Pero, et al.
ACS Chemical Neuroscience|July 21, 2012
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonistsMark E Layton, Michael J Kelly, Kevin J Rodzinak, et al.
Spine|April 12, 2024
Association Between Severity of Cervical Central Spinal Stenosis and Paraspinal Muscle Parameters in Patients Undergoing Anterior Cervical Discectomy and FusionThomas Caffard, Artine Arzani, Bruno Verna, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Global Spine Journal|May 9, 2025
Is Intraoperative Neuromonitoring with SSEPs and EMG Predictable for Postoperative Neurologic Deficit in Posterior Lumbar Fusion Surgery? A Retrospective Cohort AnalysisMarco D Burkhard, Gisberto Evangelisti, Franziska C S Altorfer, et al.
Nature Chemistry|August 25, 2017
The structure and binding mode of citrate in the stabilization of gold nanoparticlesHind Al-Johani, Edy Abou-Hamad, Abdesslem Jedidi, et al.
British Journal of Haematology|May 1, 2018
Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomesSusan K Parsons, Michael J Kelly, Joshua T Cohen, et al.
Global Spine Journal|November 6, 2024
Multifidus Degeneration: The Key Imaging Predictor of Adjacent Segment DiseaseMarco D Burkhard, Erika Chiapparelli, Jan Hambrecht, et al.
Cancer|May 26, 2017
Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropeniaAdam J Esbenshade, Zhiguo Zhao, Catherine Aftandilian, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosisMark E Layton, Alexander J Reif, Timothy J Hartingh, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDIJoseph E Pero, Michael A Rossi, Michael J Kelly, et al.
ACS Medicinal Chemistry Letters|June 18, 2021
Discovery of Arylsulfonamide Na<sub>v</sub>1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity ProfileAnthony J Roecker, Mark E Layton, Joseph E Pero, et al.
ACS Chemical Neuroscience|July 21, 2012
Discovery of 3-substituted aminocyclopentanes as potent and orally bioavailable NR2B subtype-selective NMDA antagonistsMark E Layton, Michael J Kelly, Kevin J Rodzinak, et al.
Spine|April 12, 2024
Association Between Severity of Cervical Central Spinal Stenosis and Paraspinal Muscle Parameters in Patients Undergoing Anterior Cervical Discectomy and FusionThomas Caffard, Artine Arzani, Bruno Verna, et al.
Pageof 9